TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT07313176

Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“Following a reassessment, it was concluded that continuation of the study would no longer achieve its scientific objectives originally set out for the study.”

The sponsor’s own words in the registry.

Life of this trial

202520262027Registered2025-12-17Started2026-05-08Stopped2026-08-31

Vital statistics

Status
Terminated
Sponsor
Britannia Pharmaceuticals Ltd.
Sponsor type
Industry
Conditions
Advanced Parkinson Disease
Interventions
No Intervention
Participants
1
Sites
4
Countries
Germany, Spain, United Kingdom

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.